A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding.
about
A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A CD80-Biased CTLA4-Ig Fusion ...... , Stability, and FcRn Binding.
@en
A CD80-Biased CTLA4-Ig Fusion ...... , Stability, and FcRn Binding.
@nl
type
label
A CD80-Biased CTLA4-Ig Fusion ...... , Stability, and FcRn Binding.
@en
A CD80-Biased CTLA4-Ig Fusion ...... , Stability, and FcRn Binding.
@nl
prefLabel
A CD80-Biased CTLA4-Ig Fusion ...... , Stability, and FcRn Binding.
@en
A CD80-Biased CTLA4-Ig Fusion ...... , Stability, and FcRn Binding.
@nl
P2093
P2860
P50
P356
P1476
A CD80-Biased CTLA4-Ig Fusion ...... , Stability, and FcRn Binding.
@en
P2093
Blagoje Soskic
Chris Barton
Cyril Privezentzev
D Gareth Rees
Debbie Goldberg
Inna Vainshtein
Jacques Moisan
Julie Douthwaite
Laurie Iciek
P2860
P304
P356
10.4049/JIMMUNOL.1600682
P407
P50
P577
2016-11-23T00:00:00Z